Contact Us
UBC Insights

Insights from
UBC's Expert Voices

Featured Updates

Featured Image
Blog
March 17, 2026 18 min read

Oregon Psilocybin Service Centers are a Model for Patient-Centered Care
As psychedelics move toward potential FDA approval, Oregon’s psilocybin service centers offer early lessons in patient-centered care. This article examines real-world practices in preparation, dosing, facilitation, and integration—and what they may reveal about future clinical use.
Judy Lytle
Executive Director of Evidence Development Study Solutions
Featured Image
Blog
March 9, 2026 17 min read

Breaking Barriers in Immuno-Oncology: Mechanistic Insights into Immune Checkpoint Inhibitor Resistance and Implications for Health Economics and Outcomes Research and Value Assessment
Immune checkpoint inhibitors deliver transformative outcomes, yet real‑world durability is often limited by primary and acquired resistance. This article explores the biological foundations of ICI resistance and outlines how integrating these insights into HEOR models can improve value assessment and real‑world decision‑making.
Gaurang Nazar
Senior Associate Research Scientist
Featured Image
Blog
February 26, 2026 16 min read

Redefining PV Skillsets in an AI-Driven World: Training the Next Generation of Safety Scientists
As AI becomes embedded across pharmacovigilance, the skills required of safety scientists are rapidly evolving. This article examines the shifting balance between human expertise and AI-enabled tools, outlining the competencies, training pathways, and cultural changes needed to prepare tomorrow’s hybrid PV workforce.
Christopher Henry
Safety Scientist, Global Safety Writing

Posts by Date

Happy business team talking on a meeting in the office.
Blog
July 9, 2025 6 min read

What Place for Humans in a PV World Integrating AI?
Artificial intelligence is transforming pharmacovigilance—but human expertise remains essential. As AI systems evolve to support drug safety monitoring, ensuring human oversight is key to managing risk, improving outcomes, and maintaining trust. At UBC, we’re blending AI innovation with deep PV knowledge, empowering our teams through AI awareness training and shaping a safer future for patients. Discover how AI and humans can work together to advance pharmacovigilance.
Christopher Henry
Safety Scientist, Global Safety Writing
A person interacts with a digital tablet, overlaid with glowing blue hexagonal medical and data icons, symbolizing digital healthcare technology.
Blog
June 11, 2025 4 min read

Linking real-world data with commercial patient access programs: A strategy for enhanced insights into factors that impact patient access and adherence to therapy
UBC’s approach to real-world data tokenization and linkage enhances study results with longitudinal observation of various participant health outcomes during the pre-and post-trial period.
Samuel Igweokpala
Associate Epidemiologist at UBC
People discussing using glass whiteboard and post-it notes
Blog
April 28, 2025 8 min read

Longitudinal Real-World Data: How to Gain Deeper Insights Into Your Clinical Studies
Linking longitudinal real-world data (RWD) to clinical study data offers deeper insights for drug developers. Contextualize study outcomes, extend data collection after the study ends, close the efficacy-effectiveness gap, and identify post-market patterns.
Two women in a professional setting, one smiling while looking down, suggesting collaboration or discussion.
Blog
April 15, 2025 7 min read

Evolving PV Landscape: Artificial Intelligence and Advanced Gene Therapy
UBC Pharmacovigilance experts, Dobrochna Dolicka, Christopher Henry, Alix Garcia and Irene Navarro presented at DIA Europe 2025 on how AI can be used to streamline pharmacovigilance activities and how harmonization of guidelines can be enhanced in order to define a specific framework for gene therapy.
A woman in glasses and a blazer speaks to a person, writing on a tablet during a consultation or interview.
Blog
April 4, 2025 16 min read

Unlocking the Potential of Psychedelic Therapies
Psychedelic-assisted therapies are starting to emerge with potential as treatments for mental health conditions. Explore the evidence behind an increased interest in this use of substances such as psilocybin, MDMA, LSD, and DMT, and the future of research in this area.
Catherine Miller, MSN, CRNP, FNP-BC
Senior Project Manager, Safety, Epidemiology, Registries and Risk Management
A close-up of two hands, one gently holding the other, resting on white bedsheets, conveying comfort and support.
Blog
March 4, 2025 6 min read

The Crucial Role of Adherence Support for Patients Prescribed a High-Cost Injectable or Infusion Therapy
Adherence is critical to ensuring patients receive full therapeutic benefit and effectively manage their disease, particularly for complex treatments such as injectables or infusions. Explore strategies to support patients and improve adherence in the blog.
Marci Gott
Executive Director, Patient Services
An Asian businesswoman writing on a whiteboard uring conference meeting
Blog
February 4, 2025 17 min read

Global Risk Management and Risk Evaluation and Mitigation Strategy (REMS) Developments in 2024 and Considerations for 2025
Dive deep on a number of developments occurred during 2024 that will drive considerations in risk management and REMS for 2025 and beyond.
Two women walk across a large, modern lobby with dark marble floors, flanked by wooden slatted walls and stairs.
Blog
December 4, 2024 7 min read

Driving Program Awareness through Stakeholder Collaboration
This article explores strategies to enhance Patient Service Programs (PSPs) awareness through digital engagement and provider collaboration.
A man with glasses and a beard sits on a couch, looking down at a laptop in front of him. He is wearing a light-colored shirt.
Blog
November 11, 2024 4 min read

Standardization and the Evolving REMS Landscape
Learn about the FDA's new guidance, the challenges of standardization, and how UBC is driving innovation in REMS implementation using modern APIs from UBC's VP of Data Intelligence and Program Analytics, Jim Shamp.
1 2 3 4 5 6 … 18

Press Inquires
UBC logo white

Thank You for Connecting with UBC

.

 

What You Can Expect Next

.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.